Skip to main content
OpenTrials
Completed

NCT Number: NCT04055207

VA Video Connect in HIV Care

The purpose of this research study is to see how effective the addition of video to home telehealth services is in helping patients with HIV to remain in care, which is vital to management of their illness. The investigators also want to understand how to best put the video to home services into practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Michael E. DeBakey VA Medical Center, Houston, TX

Houston, Texas, 77030-4211, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient in the Infectious Diseases clinic at Michael E. DeBakey VA Medical Center (MEDVAMC), Houston, TX, with HIV infection
  • At least 18 years of age
  • Able to speak English
  • Able to consent to the use of VVC

Exclusion criteria

  • Unable to use or consent to use VVC, due to either significant physical or mental disability
  • Incarcerated (though MEDVAMC does not generally provide care for prisoners)

Treatment and study plan

VVC

Other

Telehealth treatment is delivered via VA-approved technology to a patient's computer or mobile device.

Other names: VA Video Connect

Primary outcomes

  1. Constancy Retention in Care Measure

    Time frame: From enrollment to the end of follow-up at 12 months

    Completion of at least 1 visit with a primary care or Infectious Disease provider in each 6 months of the year at least 60 days apart.

Secondary outcomes

  1. Adherence Retention in Care Measure

    Time frame: 12 months

    Percentage of scheduled HIV clinic appointments attended over 12 months

  2. Completed Visits for Adherence Counseling

    Time frame: 12 months

    Number of completed visits for counseling, mental health, and social services during the year.

  3. HIV Suppression

    Time frame: 12 months

    Number of Veterans with HIV on ART whose most recent viral load during the 12-month period was <200c/mL

  4. Percent ART Medication Dispensed (as a Proxy for Medication Adherence)

    Time frame: 12 months

    The percentage of ART medication dispensed was calculated by dividing the total number of ART medication pills dispensed during each 365-day observation period (i.e., baseline and 12-month follow-up) by 365 and then multiplying by 100, yielding a percentage (0-100%). This pharmacy dispensing measure serves as a proxy for medication adherence, with higher percentages indicating greater medication availability.

Other outcomes

  1. CD4 Cell Count Greater Than or Equal to 200

    Time frame: 12 months

    Last recorded value in medical record during 12 month period

Sponsors and collaborators

Lead sponsor

VA Office of Research and Development

Fed

Registry information

Official study title

VA Video Connect to Improve Access to Multi-disciplinary Specialty Care

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Aug 13, 2019
Registry last updated
Aug 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.